Loosening of Teeth, an Unusual Presentation of Mucormycosis in COVID-19 Infected Patients.

Aim of our study was to report unusual presentation of mucormycosis in patients, who were recovered from COVID-19 infection. This was a prospective observational study, undertaken at Ravindra Nath Tagore Medical College, Udaipur, India, over a period of last 3 months (April-June 2021). All patients with maxillofacial and dental mucormycosis were included in the study.

Evaluation of Cognitive and Social Behavior After Adenotonsillectomy in Children.

To evaluate improvement in cognitive and social behavior of children after adenotonsillectomy. This prospective, observational study was done on 50 patients between November 2016 to September 2019 with clinical features suggestive of adenoid and palatine tonsillar hypertrophy (grade 3, 4) at department of otorhinolaryngology in our institute. We used 10 questions of Glasgow Children's Benefit Inventory (GCBI), to evaluate the cognitive and social behavior of children after adenotonsillectomy.

Narrow band imaging in early diagnosis of laryngopharyngeal malignant and premalignant lesions.

Objectives: (1) To assess the diagnostic accuracy of narrow-band imaging (NBI) in the assessment of benign, premalignant, and malignant vocal fold lesions. (2) To evaluate the diagnostic value of NBI in detection of recurrence in upper aero-digestive tract malignancy.

Methods: This was a prospective, observational study done between December 2018- November 2019 in the Department of Otolaryngology.

Correlation Between Anosmia and Severity Along with Requirement of Tocilizumab in COVID-19 Patients.

Anosmia with or without dysgeusia is frequently associated with Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) SARS-CoV-2 infection. SARS-CoV-2 virus affects the olfactory system and thus represents neurotropic and neuro-invasive nature of the virus. We found that tocilizumab's role in reducing mortality in severe covid-19 infection is still questionable and aim of our study was correlation of anosmia and severity of covid-19 infection and requirement of tocilizumab in anosmia patients.